Effectiveness of oral vancomycin as prophylaxis against Clostridioides difficile infection in hematopoietic stem cell transplant patients
Open Access
- 5 August 2024
- journal article
- research article
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 4 (1) , e107
Abstract
Objective: Patients receiving hematopoietic stem cell transplants (HSCT) are at increased risk for Clostridioides difficile infection (CDI). The purpose of this study was to assess the effectiveness of oral vancomycin prophylaxis (OVP) for CDI in HSCT patients. Design: Single-center, retrospective cohort. Setting: Tertiary care academic medical center in New Jersey. Patients: Patients ≥18 years old during admission for the HSCT were included. Patients who were admitted P = .0147). There were no significant (P > .05) between-group differences in incidence of gram-negative bloodstream infections, hospital survival, and length of stay. There were zero clinical cultures positive for VRE. Conclusions: In-hospital incidence of CDI in HSCT patients was significantly decreased with OVP. Randomized controlled trials are needed in this high-risk population to assess the efficacy and risks of OVP for CDI.Keywords
This publication has 15 references indexed in Scilit:
- Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2022
- Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to VancomycinClinical Infectious Diseases, 2021
- Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy PopulationTransplantation and Cellular Therapy, 2019
- Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility–Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic ExposureClinical Infectious Diseases, 2019
- Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy PopulationInfectious Disease Clinics of North America, 2019
- Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsClinical Infectious Diseases, 2018
- Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2017
- Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficileGastroenterology, 2014
- Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unitJournal of Hospital Infection, 2004
- ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISThe Lancet, 1978